Showing results (51-60 of 108) with videos related to
Sort By:
Pageof 11
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 18, 2015
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictorAlessandro Vitale, Fabio Farinati, Patrizia Burra, et al.Journal of Hepatology|April 11, 2014
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinomaAlessandro Cucchetti, Franco Trevisani, Anna Pecorelli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE StudyAndrea Casadei-Gardini, Giorgia Marisi, Vincenzo Dadduzio, et al.Targeted Oncology|October 28, 2020
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular CarcinomaGiulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, et al.Targeted Oncology|October 12, 2020
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular CarcinomaGiulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2025
Identification and Retrieval of Untreated HCV-Infected Individuals Lost to Follow-Up in Italy: Results From the RECALL ProjectFabio Conti, Agnese Della Vittoria, Elisa Liverani, et al.Cancers|February 6, 2021
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCsBrian I Carr, Vito Guerra, Rossella Donghia, et al.The International Journal of Biological Markers|March 1, 2021
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameterBrian I Carr, Vito Guerra, Rossella Donghia, et al.Journal of Hepatology|December 3, 2014
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre studyAlessandro Vitale, Patrizia Burra, Anna Chiara Frigo, et al.Seminars in Oncology|June 10, 2025
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world populationFrancesco Vitiello, Toshifumi Tada, Goki Suda, et al.Pageof 11